{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:13:34Z","timestamp":1791929614002,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03169-9","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T07:53:08Z","timestamp":1754898788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of advanced diagnostics on precision medicine in hemato oncology"],"prefix":"10.1007","volume":"16","author":[{"given":"Befikad","family":"Mandefro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje Mengesha","family":"Berta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanuel","family":"kelem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat Birke","family":"Teketelew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abateneh","family":"Melkamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalew","family":"Much","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewdu","family":"Mulatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiruneh","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"7574","key":"3169_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526(7574):525\u201330.","journal-title":"Nature"},{"issue":"7728","key":"3169_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018;562(7728):526\u201331.","journal-title":"Nature"},{"issue":"15","key":"3169_CR3","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/bioinformatics\/btp347","volume":"25","author":"S Assefa","year":"2009","unstructured":"Assefa S, Keane TM, Otto TD, Newbold C, Berriman M. ABACAS: algorithm-based automatic contiguation of assembled sequences. Bioinformatics. 2009;25(15):1968\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"3169_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S M\u00e9ndez-Ferrer","year":"2020","unstructured":"M\u00e9ndez-Ferrer S, Bonnet D, Steensma DP, Hasserjian RP, Ghobrial IM, Gribben JG, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20(5):285\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3169_CR5","first-page":"157","volume":"136","author":"L Malcovati","year":"2020","unstructured":"Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the international working group for the prognosis of MDS. Blood J Am Soc Hematol. 2020;136(2):157\u201370.","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"3169_CR6","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020;11(1):5327.","journal-title":"Nat Commun"},{"issue":"1","key":"3169_CR7","first-page":"12","volume":"15","author":"K Winter","year":"2021","unstructured":"Winter K, Zapf B, H\u00fctter M, Tichy N, Sassenberg K. Selective exposure in action: do visitors of product evaluation portals select reviews in a biased manner? Cyberpsychology. J Psychosoc Res Cyberspace. 2021;15(1):12.","journal-title":"J Psychosoc Res Cyberspace"},{"issue":"5","key":"3169_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jhep.2022.12.029","volume":"78","author":"B Surial","year":"2023","unstructured":"Surial B, Mena AR, Roumet M, Limacher A, Smit C, Leleux O, et al. External validation of the PAGE-B score for HCC risk prediction in people living with HIV\/HBV coinfection. J Hepatol. 2023;78(5):947\u201357.","journal-title":"J Hepatol"},{"issue":"5","key":"3169_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/diagnostics11050853","volume":"11","author":"C P\u00e9rez-Carretero","year":"2011","unstructured":"P\u00e9rez-Carretero C, Gonzalez-Gascon-y-Marin I, Rodriguez-Vicente AE, Quijada-\u00c1lamo M, Hernandez-Rivas J-a, Hernandez-Sanchez M, et al. The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment. Diagnostics. 2011;11(5):853.","journal-title":"Diagnostics."},{"issue":"11","key":"3169_CR10","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3390\/jcm9113671","volume":"9","author":"R Hehlmann","year":"2020","unstructured":"Hehlmann R. The new ELN recommendations for treating CML. J Clin Med. 2020;9(11):3671.","journal-title":"J Clin Med"},{"issue":"9","key":"3169_CR11","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41375-020-0764-6","volume":"34","author":"CA Eide","year":"2020","unstructured":"Eide CA, Kurtz SE, Kaempf A, Long N, Agarwal A, Tognon CE, et al. Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia. Leukemia. 2020;34(9):2342\u201353.","journal-title":"Leukemia"},{"issue":"2","key":"3169_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41375-021-01368-1","volume":"36","author":"LV Cappelli","year":"2022","unstructured":"Cappelli LV, Meggendorfer M, Baer C, Nadarajah N, Hutter S, Jeromin S, et al. Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration. Leukemia. 2022;36(2):394\u2013402.","journal-title":"Leukemia"},{"issue":"R2","key":"3169_CR13","doi-asserted-by":"publisher","first-page":"R188","DOI":"10.1093\/hmg\/ddq391","volume":"19","author":"L Ding","year":"2010","unstructured":"Ding L, Wendl MC, Koboldt DC, Mardis ER. Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet. 2010;19(R2):R188\u201396.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"3169_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.18.02403","volume":"37","author":"A Younes","year":"2019","unstructured":"Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, et al. Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non\u2013germinal center B-cell diffuse large B-cell lymphoma. J Clin Oncol. 2019;37(15):1285\u201395.","journal-title":"J Clin Oncol"},{"issue":"24","key":"3169_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022588","volume":"10","author":"S Marzolini","year":"2021","unstructured":"Marzolini S, Wu CY, Hussein R, Xiong LY, Kangatharan S, Peni A, et al. Associations between time after stroke and exercise training outcomes: a meta-regression analysis. J Am Heart Assoc. 2021;10(24): e022588.","journal-title":"J Am Heart Assoc"},{"issue":"100","key":"3169_CR16","first-page":"1","volume":"24","author":"D Zeng","year":"2023","unstructured":"Zeng D, Liang S, Hu X, Wang H, Xu Z. Fedlab: A flexible federated learning framework. J Mach Learn Res. 2023;24(100):1\u20137.","journal-title":"J Mach Learn Res"},{"issue":"48","key":"3169_CR17","first-page":"148","volume":"2020","author":"H-Y Huang","year":"2020","unstructured":"Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, et al. updates to the experimentally validated microRNA\u2013target interaction database. Nucl Acids Res. 2020;2020(48):148\u201354.","journal-title":"Nucl Acids Res"},{"key":"3169_CR18","first-page":"1","volume":"18","author":"VP Gallego","year":"2020","unstructured":"Gallego VP. Acerca de algunas unidades fraseol\u00f3gicas en el Arte de la Lengua Espa\u00f1ola Castellana de Gonzalo Correas: an\u00e1lisis desde una perspectiva hist\u00f3rica y did\u00e1ctica. Res Diachronicae. 2020;18:1\u201324.","journal-title":"Res Diachronicae"},{"issue":"1","key":"3169_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181(1):41\u201351.","journal-title":"JAMA Intern Med"},{"key":"3169_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40291-025-00775-9","volume":"3","author":"DG Gupta","year":"2025","unstructured":"Gupta DG, Monika VN. Bridging the gap: cost-effective strategies for detecting Ph-like B-lineage ALL in resource-limited settings. Mol Diagn Ther. 2025;3:329\u201344.","journal-title":"Mol Diagn Ther."},{"issue":"1","key":"3169_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41416-023-02294-y","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sreedharanunni S, Abdulkadir SA, Naseem S, Sachdeva MUS, et al. \u2019Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting. Br J Cancer. 2023;129(1):143\u201352.","journal-title":"Br J Cancer"},{"issue":"4","key":"3169_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12288-018-0997-y","volume":"34","author":"S Totadri","year":"2018","unstructured":"Totadri S, Singh M, Trehan A, Varma N, Bhatia P. Keeping PACE with Ph positive to Ph-like detection in B-lineage acute lymphoblastic leukemia: a practical and cost effective (PACE) approach in a resource constrained setting. Indian J Hematol Blood Transfus. 2018;34(4):595\u2013601.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"3169_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/10428194.2021.1999439","volume":"63","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Binota J, et al. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2022;63(3):633\u201343.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"3169_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncr.35051","volume":"130","author":"DG Gupta","year":"2024","unstructured":"Gupta DG, Varma N, Abdulkadir SA, Sreedharanunni S, Sachdeva MUS, Naseem S, et al. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia. Cancer. 2024;130(5):713\u201326.","journal-title":"Cancer"},{"issue":"10223","key":"3169_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China The lancet. 2020;395(10223):497\u2013506.","journal-title":"China The lancet"},{"key":"3169_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijid.2020.04.027","volume":"96","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li H-B, Lyu J-R, Lei X-M, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020;96:19\u201324.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"3169_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ajpa.21019","volume":"139","author":"H Schroeder","year":"2009","unstructured":"Schroeder H, O\u2019Connell TC, Evans JA, Shuler KA, Hedges RE. Trans-Atlantic slavery: isotopic evidence for forced migration to Barbados. Am J Phy Anthropol Off Publ Am Assoc Phys Anthropol. 2009;139(4):547\u201357.","journal-title":"Am J Phy Anthropol Off Publ Am Assoc Phys Anthropol"},{"issue":"3","key":"3169_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2017.1356900","volume":"5","author":"NA Gloushankova","year":"2017","unstructured":"Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue barriers. 2017;5(3): e1356900.","journal-title":"Tissue barriers"},{"issue":"1","key":"3169_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/leu.2013.248","volume":"28","author":"DA Landau","year":"2014","unstructured":"Landau DA, Carter SL, Getz G, Wu CJ. Clonal evolution in hematological malignancies and therapeutic implications. Leukemia. 2014;28(1):34\u201343.","journal-title":"Leukemia"},{"issue":"2","key":"3169_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3324\/haematol.2022.282442","volume":"109","author":"R Kwon","year":"2024","unstructured":"Kwon R, Yeung CC. Advances in next-generation sequencing and emerging technologies for hematologic malignancies. Haematologica. 2024;109(2):379.","journal-title":"Haematologica"},{"key":"3169_CR31","doi-asserted-by":"crossref","unstructured":"Research SGfCC. 2022. Supplementum 265: Abstracts of the Swiss Oncology & Hematology Congress (SOHC), November. Swiss Medical Weekly. 152(4546):265","DOI":"10.57187\/smw.2022.40034"},{"issue":"Supplement 1","key":"3169_CR32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1182\/blood-2022-169029","volume":"140","author":"RE Prince","year":"2022","unstructured":"Prince RE, Schaeper U, Aretz J, Li B, Reina Caro MD, Eisermann M, et al. SLN140 a small interfering RNA targeting protein S improves hemostasis potency in hemophilia. Blood. 2022;140(Supplement 1):1670\u20131.","journal-title":"Blood"},{"key":"3169_CR33","doi-asserted-by":"publisher","first-page":"102883","DOI":"10.1016\/j.artmed.2024.102883","volume":"12","author":"H Patel","year":"2024","unstructured":"Patel H, Shah H, Patel G, Patel A. Hematologic cancer diagnosis and classification using machine and deep learning: state-of-the-art techniques and emerging research directives. Artif Intell Med. 2024;12:102883.","journal-title":"Artif Intell Med"},{"key":"3169_CR34","first-page":"1","volume":"12","author":"MT Patel","year":"2025","unstructured":"Patel MT, Goldberg Oppenheimer PG. Advancements in cancer diagnostics: integrating surface-enhanced Raman spectroscopy and microptofluidics for precision and versatility. Appl Spectrosc Rev. 2025;12:1\u201344.","journal-title":"Appl Spectrosc Rev"},{"issue":"19","key":"3169_CR35","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.3390\/cancers16193339","volume":"16","author":"W Ploch","year":"2024","unstructured":"Ploch W, Sadowski K, Olejarz W, Basak GW. Advancement and challenges in monitoring of CAR-T cell therapy: a comprehensive review of parameters and markers in hematological malignancies. Cancers. 2024;16(19):3339.","journal-title":"Cancers"},{"issue":"6","key":"3169_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1158\/1535-7163.MCT-16-0876","volume":"16","author":"M Larrosa-Garcia","year":"2017","unstructured":"Larrosa-Garcia M, Baer MR. FLT3 inhibitors in acute myeloid leukemia: current status and future directions. Mol Cancer Ther. 2017;16(6):991\u20131001.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"3169_CR37","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/cancers16111996","volume":"16","author":"A Galitzia","year":"2024","unstructured":"Galitzia A, Maccaferri M, Mauro FR, Murru R, Marasca R. Chronic lymphocytic leukemia: management of adverse events in the era of targeted agents. Cancers. 2024;16(11):1996.","journal-title":"Cancers"},{"issue":"11","key":"3169_CR38","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3390\/cancers15112883","volume":"15","author":"G Solomou","year":"2023","unstructured":"Solomou G, Finch A, Asghar A, Bardella C. Mutant IDH in gliomas: role in cancer and treatment options. Cancers. 2023;15(11):2883.","journal-title":"Cancers"},{"issue":"17","key":"3169_CR39","first-page":"12","volume":"10","author":"T Wang","year":"2024","unstructured":"Wang T, Cui S, Lyu C, Wang Z, Li Z, Han C, et al. Molecular precision medicine: multi-omics-based stratification model for acute myeloid leukemia. Heliyon. 2024;10(17):12.","journal-title":"Heliyon."},{"issue":"4","key":"3169_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","volume":"23","author":"ST Barry","year":"2023","unstructured":"Barry ST, Gabrilovich DI, Sansom OJ, Campbell AD, Morton JP. Therapeutic targeting of tumour myeloid cells. Nat Rev Cancer. 2023;23(4):216\u201337.","journal-title":"Nat Rev Cancer"},{"key":"3169_CR41","volume-title":"Examining symptom burden and the palliative care needs of patients with hematologic malignancies","author":"R Booker","year":"2024","unstructured":"Booker R. Examining symptom burden and the palliative care needs of patients with hematologic malignancies. Victoria: University of Victoria; 2024."},{"issue":"3","key":"3169_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40291-025-00779-5","volume":"29","author":"S Sreedharanunni","year":"2025","unstructured":"Sreedharanunni S, Thakur V, Balakrishnan A, Sachdeva MUS, Kaur P, Raina S, et al. effective utilization of a customized targeted hybrid capture rna sequencing in the routine molecular categorization of adolescent and adult b-lineage acute lymphoblastic leukemia: a real-world experience. Mol Diagn Ther. 2025;29(3):407\u201318.","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"3169_CR43","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1097\/MPH.0000000000001892","volume":"43","author":"P Sharma","year":"2021","unstructured":"Sharma P, Rana S, Sreedharanunni S, Gautam A, Sachdeva MUS, Naseem S, et al. An evaluation of a fluorescence in situ hybridization strategy using air-dried blood and bone-marrow smears in the risk stratification of pediatric b-lineage acute lymphoblastic leukemia in resource-limited settings. J Pediatr Hematol Oncol. 2021;43(4):e481\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"3169_CR44","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00277-021-04574-0","volume":"100","author":"H Virk","year":"2021","unstructured":"Virk H, Rana S, Sharma P, Bose PL, Yadav DD, Sachdeva MUS, et al. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. Ann Hematol. 2021;100(8):2031\u201341.","journal-title":"Ann Hematol"},{"issue":"2","key":"3169_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ijlh.14213","volume":"46","author":"P Sharma","year":"2024","unstructured":"Sharma P, Bose P, Mallik N, Gupta DG, Rachagiri S, Kumar A, et al. FLAER as a standalone reagent for paroxysmal nocturnal hemoglobinuria: do we need to reconsider the guidelines for testing? Int J Lab Hematol. 2024;46(2):383\u20139.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"3169_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.galenos.2021.2021.0326","volume":"39","author":"DG Gupta","year":"2022","unstructured":"Gupta DG, Varma N, Naseem S, Sachdeva MUS, Bose P, Binota J, et al. Characterization of immunophenotypic aberrancies with respect to common fusion transcripts in B-cell precursor acute lymphoblastic leukemia: a report of 986 indian patients. Turk J Haematol. 2022;39(1):1\u201312.","journal-title":"Turk J Haematol"},{"issue":"7","key":"3169_CR47","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/jcm9072125","volume":"9","author":"M Melas","year":"2020","unstructured":"Melas M, Subbiah S, Saadat S, Rajurkar S, McDonnell KJ. The community oncology and academic medical center alliance in the age of precision medicine: cancer genetics and genomics considerations. J Clin Med. 2020;9(7):2125.","journal-title":"J Clin Med"},{"issue":"1","key":"3169_CR48","first-page":"65","volume":"2","author":"S Ovejero","year":"2021","unstructured":"Ovejero S, Moreaux J. Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. Exploration of Targeted Anti-tumor Ther. 2021;2(1):65.","journal-title":"Exploration of Targeted Anti-tumor Ther"},{"issue":"3","key":"3169_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/1871520621666210308101029","volume":"22","author":"D Advani","year":"2022","unstructured":"Advani D, Sharma S, Kumari S, Ambasta RK, Kumar P. Precision oncology signaling and anticancer agents in cancer therapeutics. Anti-Cancer Agents in Med Chem-Anti-Cancer Agents. 2022;22(3):433\u201368.","journal-title":"Anti-Cancer Agents in Med Chem-Anti-Cancer Agents"},{"issue":"21","key":"3169_CR50","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/cncr.34957","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Sharma P, Truica MI, Abdulkadir SA, Singh P, et al. Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: a report of 1021 patients from India. Cancer. 2023;129(21):3390\u2013404.","journal-title":"Cancer"},{"issue":"6","key":"3169_CR51","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.chembiol.2023.05.007","volume":"30","author":"ML Arwood","year":"2023","unstructured":"Arwood ML, Liu Y, Harkins SK, Weinstock DM, Yang L, Stevenson KE, et al. New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell Chem Biol. 2023;30(6):618-31.e12.","journal-title":"Cell Chem Biol"},{"issue":"18","key":"3169_CR52","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3390\/cancers13184582","volume":"13","author":"G Riva","year":"2021","unstructured":"Riva G, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Forghieri F, et al. Multiparametric flow cytometry for MRD monitoring in hematologic malignancies: clinical applications and new challenges. Cancers. 2021;13(18):4582.","journal-title":"Cancers"},{"issue":"2","key":"3169_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/2159-8290.CD-21-0538","volume":"12","author":"C Kornauth","year":"2022","unstructured":"Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S, et al. Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders. Cancer Discov. 2022;12(2):372\u201387.","journal-title":"Cancer Discov"},{"key":"3169_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.766869","volume":"9","author":"R Sharma","year":"2022","unstructured":"Sharma R, Kannourakis G, Prithviraj P, Ahmed N. Precision medicine: an optimal approach to patient care in renal cell carcinoma. Front Med. 2022;9: 766869.","journal-title":"Front Med"},{"issue":"8","key":"3169_CR55","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.34665","volume":"129","author":"DG Gupta","year":"2023","unstructured":"Gupta DG, Varma N, Kumar A, Naseem S, Sachdeva MUS, Sreedharanunni S, et al. Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: a report of Indian patients. Cancer. 2023;129(8):1217\u201326.","journal-title":"Cancer"},{"issue":"1","key":"3169_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1152\/physrev.00004.2022","volume":"103","author":"MA Evans","year":"2023","unstructured":"Evans MA, Walsh K. Clonal hematopoiesis, somatic mosaicism, and age-associated disease. Physiol Rev. 2023;103(1):649\u2013716.","journal-title":"Physiol Rev"},{"key":"3169_CR57","unstructured":"FERREIRA BV. The role of extracellular vesicles in multiple myeloma. NOVA University Lisbon; 2021."},{"key":"3169_CR58","doi-asserted-by":"publisher","DOI":"10.1201\/9781003180449","volume-title":"Advances in Medical Biochemistry, Genomics, Physiology, and Pathology","author":"R Bawa","year":"2021","unstructured":"Bawa R, Chang EH, Audette GF, Diwan A, Faiz SA. Advances in Medical Biochemistry, Genomics, Physiology, and Pathology. New York: Jenny Stanford Publishing; 2021."},{"issue":"21","key":"3169_CR59","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3390\/cancers13215364","volume":"13","author":"N Honor\u00e9","year":"2021","unstructured":"Honor\u00e9 N, Galot R, van Marcke C, Limaye N, Machiels J-P. Liquid biopsy to detect minimal residual disease: methodology and impact. Cancers. 2021;13(21):5364.","journal-title":"Cancers"},{"issue":"7","key":"3169_CR60","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-22-0087","volume":"21","author":"S Corvigno","year":"2022","unstructured":"Corvigno S, Johnson AM, Wong K-K, Cho MS, Afshar-Kharghan V, Menter DG, et al. Novel markers for liquid biopsies in cancer management: circulating platelets and extracellular vesicles. Mol Cancer Ther. 2022;21(7):1067\u201375.","journal-title":"Mol Cancer Ther"},{"key":"3169_CR61","doi-asserted-by":"publisher","first-page":"1173701","DOI":"10.3389\/fonc.2023.1173701","volume":"13","author":"M Bou Zerdan","year":"2023","unstructured":"Bou Zerdan M, Kassab J, Saba L, Haroun E, Bou Zerdan M, Allam S, et al. Liquid biopsies and minimal residual disease in lymphoid malignancies. Front Oncol. 2023;13:1173701.","journal-title":"Front Oncol"},{"issue":"9","key":"3169_CR62","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.3390\/ijms21093141","volume":"21","author":"N Coccaro","year":"2020","unstructured":"Coccaro N, Tota G, Anelli L, Zagaria A, Specchia G, Albano F. Digital PCR: a reliable tool for analyzing and monitoring hematologic malignancies. Int J Mol Sci. 2020;21(9):3141.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"3169_CR63","first-page":"2273","volume":"139","author":"YM Akkari","year":"2022","unstructured":"Akkari YM, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, et al. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood J Am Soc Hematol. 2022;139(15):2273\u201384.","journal-title":"Blood J Am Soc Hematol"},{"key":"3169_CR64","volume-title":"Ultrasensitive molecular monitoring of breast cancer and acute myeloid leukemia","author":"Y Chen","year":"2021","unstructured":"Chen Y. Ultrasensitive molecular monitoring of breast cancer and acute myeloid leukemia. New York: Lund University; 2021."},{"issue":"3","key":"3169_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41375-020-01104-1","volume":"35","author":"S Trino","year":"2021","unstructured":"Trino S, Lamorte D, Caivano A, De Luca L, Sgambato A, Laurenzana I. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy. Leukemia. 2021;35(3):661\u201378.","journal-title":"Leukemia"},{"key":"3169_CR66","doi-asserted-by":"publisher","first-page":"1164517","DOI":"10.3389\/fonc.2023.1164517","volume":"13","author":"D Talotta","year":"2023","unstructured":"Talotta D, Almasri M, Cosentino C, Gaidano G, Moia R. Liquid biopsy in hematological malignancies: current and future applications. Front Oncol. 2023;13:1164517.","journal-title":"Front Oncol"},{"issue":"1","key":"3169_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41698-019-0095-0","volume":"3","author":"SB Lim","year":"2019","unstructured":"Lim SB, Di Lee W, Vasudevan J, Lim W-T, Lim CT. Liquid biopsy: one cell at a time. NPJ precision oncology. 2019;3(1):23.","journal-title":"NPJ precision oncology"},{"key":"3169_CR68","doi-asserted-by":"publisher","DOI":"10.1201\/9781003197935","volume-title":"Flow cytometry in neoplastic hematology: morphologic-immunophenotypic-genetic correlation","author":"W Gorczyca","year":"2022","unstructured":"Gorczyca W. Flow cytometry in neoplastic hematology: morphologic-immunophenotypic-genetic correlation. Berlin: CRC Press; 2022."},{"key":"3169_CR69","doi-asserted-by":"crossref","unstructured":"Smith C. The development and characterization of nanobodies specific to protein tyrosine phosphatase 4a3 (PTP4A3\/PRL-3) to dissect and target its role in cancer. 2023.","DOI":"10.1158\/1538-7445.AM2022-672"},{"issue":"4","key":"3169_CR70","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","volume":"64","author":"G Papatheodoridis","year":"2016","unstructured":"Papatheodoridis G, Dalekos G, Sypsa V, Yurdaydin C, Buti M, Goulis J, et al. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J Hepatol. 2016;64(4):800\u20136.","journal-title":"J Hepatol"},{"key":"3169_CR71","doi-asserted-by":"publisher","first-page":"1487234","DOI":"10.3389\/fmed.2024.1487234","volume":"11","author":"S-X Wang","year":"2024","unstructured":"Wang S-X, Huang Z-F, Li J, Wu Y, Du J, Li T. Optimization of diagnosis and treatment of hematological diseases via artificial intelligence. Front Med. 2024;11:1487234.","journal-title":"Front Med"},{"issue":"1","key":"3169_CR72","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-023-01514-5","volume":"16","author":"C Zhang","year":"2023","unstructured":"Zhang C, Xu J, Tang R, Yang J, Wang W, Yu X, et al. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment. J Hematol Oncol. 2023;16(1):114.","journal-title":"J Hematol Oncol"},{"key":"3169_CR73","first-page":"2024","volume-title":"Evolution of haematology in India: a haematologist's perspective","author":"M Bhargava","year":"2024","unstructured":"Bhargava M. Evolution of haematology in India: a haematologist\u2019s perspective. Cambridge: Cambridge Scholars Publishing; 2024. p. 2024."},{"issue":"11","key":"3169_CR74","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.3390\/ijms23116281","volume":"23","author":"E Nevedomskaya","year":"2022","unstructured":"Nevedomskaya E, Haendler B. From omics to multi-omics approaches for in-depth analysis of the molecular mechanisms of prostate cancer. Int J Mol Sci. 2022;23(11):6281.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3169_CR75","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/cancers14051310","volume":"14","author":"R Colmenares","year":"2022","unstructured":"Colmenares R, \u00c1lvarez N, Barrio S, Mart\u00ednez-L\u00f3pez J, Ayala R. The minimal residual disease using liquid biopsies in hematological malignancies. Cancers. 2022;14(5):1310.","journal-title":"Cancers"},{"issue":"10","key":"3169_CR76","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1039\/D0LC01235A","volume":"21","author":"R An","year":"2021","unstructured":"An R, Huang Y, Man Y, Valentine RW, Kucukal E, Goreke U, et al. Emerging point-of-care technologies for anemia detection. Lab Chip. 2021;21(10):1843\u201365.","journal-title":"Lab Chip"},{"issue":"4","key":"3169_CR77","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/D3SD00304C","volume":"3","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S. Democratizing nucleic acid-based molecular diagnostic tests for infectious diseases at resource-limited settings\u2013from point of care to extreme point of care. Sens Diagn. 2024;3(4):536\u201361.","journal-title":"Sens Diagn"},{"key":"3169_CR78","doi-asserted-by":"publisher","DOI":"10.1201\/9781315374161","volume-title":"Bioequivalence and statistics in clinical pharmacology","author":"SD Patterson","year":"2017","unstructured":"Patterson SD, Jones B. Bioequivalence and statistics in clinical pharmacology. Cambridge: Chapman and Hall\/CRC; 2017."},{"key":"3169_CR79","doi-asserted-by":"publisher","first-page":"117955492412985","DOI":"10.1177\/11795549241298541","volume":"18","author":"M AlDoughaim","year":"2024","unstructured":"AlDoughaim M, AlSuhebany N, AlZahrani M, AlQahtani T, AlGhamdi S, Badreldin H, et al. Cancer biomarkers and precision oncology: a review of recent trends and innovations. Clin Med Insights Oncol. 2024;18:11795549241298540.","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"3169_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/clinchem\/hvad179","volume":"70","author":"T Mamo","year":"2024","unstructured":"Mamo T, Dreyzin A, Stroncek D, McKenna DH. Emerging biomarkers for monitoring chimeric antigen receptor T-cell therapy. Clin Chem. 2024;70(1):116\u201327.","journal-title":"Clin Chem"},{"issue":"35","key":"3169_CR81","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1080\/14796694.2024.2390821","volume":"20","author":"A Ferreira-Gonzalez","year":"2024","unstructured":"Ferreira-Gonzalez A, Ko G, Fusco N, Stewart F, Kistler K, Appukkuttan S, et al. Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review. Future Oncol. 2024;20(35):2765\u201377.","journal-title":"Future Oncol"},{"key":"3169_CR82","volume-title":"Cancer and AIDS: Part IV: Future perspectives","author":"CKO Williams","year":"2018","unstructured":"Williams CKO. Cancer and AIDS: Part IV: Future perspectives. Berlin: Springer; 2018."},{"issue":"19","key":"3169_CR83","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.3390\/cancers15194816","volume":"15","author":"D-Y Shin","year":"2023","unstructured":"Shin D-Y. TP53 mutation in acute myeloid leukemia: an old foe revisited. Cancers. 2023;15(19):4816.","journal-title":"Cancers"},{"issue":"3","key":"3169_CR84","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/biomedicines12030599","volume":"12","author":"J Moritz","year":"2024","unstructured":"Moritz J, Schwab A, Reinisch A, Zebisch A, Sill H, W\u00f6lfler A. Measurable residual disease detection in acute myeloid leukemia: current challenges and future directions. Biomedicines. 2024;12(3):599.","journal-title":"Biomedicines"},{"issue":"5","key":"3169_CR85","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.molmed.2020.01.012","volume":"26","author":"E Heitzer","year":"2020","unstructured":"Heitzer E, Auinger L, Speicher MR. Cell-free DNA and apoptosis: how dead cells inform about the living. Trends Mol Med. 2020;26(5):519\u201328.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3169_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1373\/clinchem.2019.306837","volume":"66","author":"R Lampignano","year":"2020","unstructured":"Lampignano R, Neumann MH, Weber S, Kloten V, Herdean A, Voss T, et al. Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (pre) analytical work flows. Clin Chem. 2020;66(1):149\u201360.","journal-title":"Clin Chem"},{"issue":"9","key":"3169_CR87","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.3390\/ijms25094644","volume":"25","author":"C Jim\u00e9nez","year":"2024","unstructured":"Jim\u00e9nez C, Garrote-de-Barros A, L\u00f3pez-Portugu\u00e9s C, Hern\u00e1ndez-S\u00e1nchez M, D\u00edez P. Characterization of human B cell hematological malignancies using protein-based approaches. Int J Mol Sci. 2024;25(9):4644.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3169_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12992-024-01049-5","volume":"20","author":"RGL da Silva","year":"2024","unstructured":"da Silva RGL. The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies. Glob Health. 2024;20(1):44.","journal-title":"Glob Health"},{"issue":"7","key":"3169_CR89","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A, et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024;187(7):1589\u2013616.","journal-title":"Cell"},{"issue":"19","key":"3169_CR90","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3390\/cancers13194887","volume":"13","author":"M Duchmann","year":"2021","unstructured":"Duchmann M, Laplane L, Itzykson R. Clonal architecture and evolutionary dynamics in acute myeloid leukemias. Cancers. 2021;13(19):4887.","journal-title":"Cancers"},{"issue":"14","key":"3169_CR91","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/cancers13143587","volume":"13","author":"B Lebecque","year":"2021","unstructured":"Lebecque B, Bourgne C, Vidal V, Berger MG. DNA methylation and intra-clonal heterogeneity: the chronic myeloid leukemia model. Cancers. 2021;13(14):3587.","journal-title":"Cancers"},{"issue":"1","key":"3169_CR92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1373\/clinchem.2019.304774","volume":"66","author":"E Heitzer","year":"2020","unstructured":"Heitzer E. Point: circulating tumor DNA for modern cancer management. Clin Chem. 2020;66(1):143\u20135.","journal-title":"Clin Chem"},{"issue":"9","key":"3169_CR93","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/clinchem\/hvae079","volume":"70","author":"L Bonstingl","year":"2024","unstructured":"Bonstingl L, Skofler C, Ulz C, Zinnegger M, Sallinger K, Sch\u00f6nberger J, et al. Clinical application of ISO and CEN\/TS standards for liquid biopsies\u2014information everybody wants but nobody wants to pay for. Clin Chem. 2024;70(9):1140\u201350.","journal-title":"Clin Chem"},{"key":"3169_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.101019","volume":"58","author":"W Walter","year":"2023","unstructured":"Walter W, Pohlkamp C, Meggendorfer M, Nadarajah N, Kern W, Haferlach C, et al. Artificial intelligence in hematological diagnostics: game changer or gadget? Blood Rev. 2023;58: 101019.","journal-title":"Blood Rev"},{"issue":"2","key":"3169_CR95","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ijlh.14033","volume":"45","author":"T Haferlach","year":"2023","unstructured":"Haferlach T, Walter W. Challenging gold standard hematology diagnostics through the introduction of whole genome sequencing and artificial intelligence. Int J Lab Hematol. 2023;45(2):156\u201362.","journal-title":"Int J Lab Hematol"},{"key":"3169_CR96","volume-title":"Next-generation sequencing and emerging technologies Seminars in thrombosis and hemostasis","author":"KR Kumar","year":"2024","unstructured":"Kumar KR, Cowley MJ, Davis RL. Next-generation sequencing and emerging technologies Seminars in thrombosis and hemostasis. New York: Thieme Medical Publishers; 2024."},{"issue":"15","key":"3169_CR97","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.3390\/cancers14153612","volume":"14","author":"R Ancos-Pintado","year":"2022","unstructured":"Ancos-Pintado R, Bragado-Garc\u00eda I, Morales ML, Garc\u00eda-Vicente R, Arroyo-Barea A, Rodr\u00edguez-Garc\u00eda A, et al. High-throughput CRISPR screening in hematological neoplasms. Cancers. 2022;14(15):3612.","journal-title":"Cancers"},{"key":"3169_CR98","unstructured":"Henczel LJ. Improving Screening and Referral for Hereditary Cancers in New Breast Cancer Patients: Grand Canyon University; 2021."},{"issue":"4&5","key":"3169_CR99","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","volume":"156","author":"K Sathishkumar","year":"2022","unstructured":"Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from national cancer registry programme. India Indian J Med Res. 2022;156(4&5):598\u2013607.","journal-title":"India Indian J Med Res"},{"key":"3169_CR100","first-page":"187249812413065","volume":"12","author":"A Chaturvedi","year":"2024","unstructured":"Chaturvedi A, Pathak N, Sharma N, Malik P. Theoretical advancements in deep learning for hematological cancer diagnosis: proposing a new framework and mathematical model. Intell Decision Technol. 2024;12:18724981241306504.","journal-title":"Intell Decision Technol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03169-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03169-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03169-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:34:47Z","timestamp":1757378087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03169-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3169"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03169-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review solely utilized scientific background information and findings from other research studies. No patient data was used, and there was no direct participant involvement. All information was carefully reviewed to ensure adherence to ethical guidelines and standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual persons\u2019 data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1525"}}